These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 35472304)

  • 1. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
    PHOSP-COVID Collaborative Group
    Lancet Respir Med; 2022 Aug; 10(8):761-775. PubMed ID: 35472304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
    Evans RA; McAuley H; Harrison EM; Shikotra A; Singapuri A; Sereno M; Elneima O; Docherty AB; Lone NI; Leavy OC; Daines L; Baillie JK; Brown JS; Chalder T; De Soyza A; Diar Bakerly N; Easom N; Geddes JR; Greening NJ; Hart N; Heaney LG; Heller S; Howard L; Hurst JR; Jacob J; Jenkins RG; Jolley C; Kerr S; Kon OM; Lewis K; Lord JM; McCann GP; Neubauer S; Openshaw PJM; Parekh D; Pfeffer P; Rahman NM; Raman B; Richardson M; Rowland M; Semple MG; Shah AM; Singh SJ; Sheikh A; Thomas D; Toshner M; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Wain LV; Brightling CE;
    Lancet Respir Med; 2021 Nov; 9(11):1275-1287. PubMed ID: 34627560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
    Jackson C; Stewart ID; Plekhanova T; Cunningham PS; Hazel AL; Al-Sheklly B; Aul R; Bolton CE; Chalder T; Chalmers JD; Chaudhuri N; Docherty AB; Donaldson G; Edwardson CL; Elneima O; Greening NJ; Hanley NA; Harris VC; Harrison EM; Ho LP; Houchen-Wolloff L; Howard LS; Jolley CJ; Jones MG; Leavy OC; Lewis KE; Lone NI; Marks M; McAuley HJC; McNarry MA; Patel BV; Piper-Hanley K; Poinasamy K; Raman B; Richardson M; Rivera-Ortega P; Rowland-Jones SL; Rowlands AV; Saunders RM; Scott JT; Sereno M; Shah AM; Shikotra A; Singapuri A; Stanel SC; Thorpe M; Wootton DG; Yates T; Gisli Jenkins R; Singh SJ; Man WD; Brightling CE; Wain LV; Porter JC; Thompson AAR; Horsley A; Molyneaux PL; Evans RA; Jones SE; Rutter MK; Blaikley JF;
    Lancet Respir Med; 2023 Aug; 11(8):673-684. PubMed ID: 37072018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
    Taquet M; Skorniewska Z; De Deyn T; Hampshire A; Trender WR; Hellyer PJ; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Rogers N; Houchen-Wolloff L; Greening NJ; Mansoori P; Harrison EM; Docherty AB; Lone NI; Quint J; Brightling CE; Wain LV; Evans RA; Geddes JR; Harrison PJ;
    Lancet Psychiatry; 2024 Sep; 11(9):696-708. PubMed ID: 39096931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
    C-MORE/PHOSP-COVID Collaborative Group
    Lancet Respir Med; 2023 Nov; 11(11):1003-1019. PubMed ID: 37748493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
    McAuley HJC; Evans RA; Bolton CE; Brightling CE; Chalmers JD; Docherty AB; Elneima O; Greenhaff PL; Gupta A; Harris VC; Harrison EM; Ho LP; Horsley A; Houchen-Wolloff L; Jolley CJ; Leavy OC; Lone NI; Man WD; Marks M; Parekh D; Poinasamy K; Quint JK; Raman B; Richardson M; Saunders RM; Sereno M; Shikotra A; Singapuri A; Singh SJ; Steiner M; Tan AL; Wain LV; Welch C; Whitney J; Witham MD; Lord J; Greening NJ;
    EClinicalMedicine; 2023 Mar; 57():101896. PubMed ID: 36936404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
    Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
    BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Huang L; Yao Q; Gu X; Wang Q; Ren L; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J; Wang X; Cao B
    Lancet; 2021 Aug; 398(10302):747-758. PubMed ID: 34454673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
    Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
    Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
    Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
    Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.
    Dryden M; Mudara C; Vika C; Blumberg L; Mayet N; Cohen C; Tempia S; Parker A; Nel J; Perumal R; Groome MJ; Conradie F; Ndjeka N; Sigfrid L; Merson L; Jassat W
    Lancet Glob Health; 2022 Sep; 10(9):e1247-e1256. PubMed ID: 35961348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study.
    Betschart M; Rezek S; Unger I; Ott N; Beyer S; Böni A; Gisi D; Shannon H; Spruit MA; Sieber C
    Swiss Med Wkly; 2021 Oct; 151():w30072. PubMed ID: 34751538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Long-COVID-19 and its Impact on Quality of Life: Longitudinal Analysis at 3, 6 and 9 Months after Discharge from a Portuguese Centre.
    Gaspar P; Dias M; Parreira I; Gonçalves HD; Parlato F; Maione V; Atalaia Barbacena H; Carreiro C; Duarte L
    Acta Med Port; 2023 Oct; 36(10):647-660. PubMed ID: 36827994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.